Sumitomo Pharma Co., Ltd. insider trades: Roivant Sciences (ROIV) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sumitomo Pharma Co., Ltd. reports to the SEC
Open-market buys and sales
43 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 22, 2023 | ROIV | ↓ Sell | 15,116,277 | $8.60 | $130.0M | Indirect | Jun 26, 2023 (4d) |
| Mar 10, 2023 | MYOV | ↑ Buy | 51,599,200 | $27.00 | $1.39B | Indirect | Mar 10, 2023 (0d) |
| Sep 28, 2021 | MYOV | ↑ Buy10b5-1 | 20,677 | $22.85 | $472K | Indirect | Sep 30, 2021 (2d) |
| Sep 27, 2021 | MYOV | ↑ Buy10b5-1 | 84,000 | $23.87 | $2.0M | Indirect | Sep 28, 2021 (1d) |
| Sep 23, 2021 | MYOV | ↑ Buy10b5-1 | 138,796 | $22.39 | $3.1M | Indirect | Sep 24, 2021 (1d) |
| Sep 21, 2021 | MYOV | ↑ Buy10b5-1 | 81,273 | $22.30 | $1.8M | Indirect | Sep 22, 2021 (1d) |
| Sep 17, 2021 | MYOV | ↑ Buy10b5-1 | 87,913 | $22.20 | $2.0M | Indirect | Sep 20, 2021 (3d) |
| Sep 15, 2021 | MYOV | ↑ Buy10b5-1 | 161,164 | $22.03 | $3.6M | Indirect | Sep 16, 2021 (1d) |
| Sep 13, 2021 | MYOV | ↑ Buy10b5-1 | 113,178 | $23.84 | $2.7M | Indirect | Sep 14, 2021 (1d) |
| Sep 9, 2021 | MYOV | ↑ Buy10b5-1 | 58,902 | $25.60 | $1.5M | Indirect | Sep 10, 2021 (1d) |
| Sep 7, 2021 | MYOV | ↑ Buy10b5-1 | 64,400 | $26.49 | $1.7M | Indirect | Sep 8, 2021 (1d) |
| Sep 2, 2021 | MYOV | ↑ Buy10b5-1 | 103,102 | $25.60 | $2.6M | Indirect | Sep 3, 2021 (1d) |
| Aug 31, 2021 | MYOV | ↑ Buy10b5-1 | 109,000 | $24.05 | $2.6M | Indirect | Sep 1, 2021 (1d) |
| Aug 27, 2021 | MYOV | ↑ Buy10b5-1 | 77,038 | $22.91 | $1.8M | Indirect | Aug 30, 2021 (3d) |
| Aug 25, 2021 | MYOV | ↑ Buy10b5-1 | 63,008 | $22.40 | $1.4M | Indirect | Aug 26, 2021 (1d) |
| Aug 23, 2021 | MYOV | ↑ Buy10b5-1 | 101,925 | $21.65 | $2.2M | Indirect | Aug 24, 2021 (1d) |
| Aug 19, 2021 | MYOV | ↑ Buy10b5-1 | 63,908 | $21.49 | $1.4M | Indirect | Aug 20, 2021 (1d) |
| Aug 17, 2021 | MYOV | ↑ Buy10b5-1 | 71,716 | $21.21 | $1.5M | Indirect | Aug 18, 2021 (1d) |
| May 20, 2020 | MYOV | ↑ Buy10b5-1 | 87,897 | $12.31 | $1.1M | Indirect | May 21, 2020 (1d) |
| May 18, 2020 | MYOV | ↑ Buy10b5-1 | 84,812 | $12.22 | $1.0M | Indirect | May 19, 2020 (1d) |
| May 14, 2020 | MYOV | ↑ Buy10b5-1 | 91,331 | $12.18 | $1.1M | Indirect | May 15, 2020 (1d) |
| May 12, 2020 | MYOV | ↑ Buy10b5-1 | 59,448 | $13.08 | $778K | Indirect | May 13, 2020 (1d) |
| May 8, 2020 | MYOV | ↑ Buy10b5-1 | 70,000 | $12.73 | $891K | Indirect | May 11, 2020 (3d) |
| May 5, 2020 | MYOV | ↑ Buy10b5-1 | 100,000 | $11.97 | $1.2M | Indirect | May 7, 2020 (2d) |
| May 4, 2020 | MYOV | ↑ Buy10b5-1 | 100,000 | $11.44 | $1.1M | Indirect | May 5, 2020 (1d) |
| Apr 30, 2020 | MYOV | ↑ Buy10b5-1 | 100,000 | $12.00 | $1.2M | Indirect | May 1, 2020 (1d) |
| Apr 28, 2020 | MYOV | ↑ Buy10b5-1 | 90,503 | $12.11 | $1.1M | Indirect | Apr 29, 2020 (1d) |
| Apr 24, 2020 | MYOV | ↑ Buy10b5-1 | 78,086 | $12.24 | $955K | Indirect | Apr 27, 2020 (3d) |
| Apr 22, 2020 | MYOV | ↑ Buy10b5-1 | 100,200 | $11.76 | $1.2M | Indirect | Apr 23, 2020 (1d) |
| Apr 20, 2020 | MYOV | ↑ Buy10b5-1 | 120,300 | $11.20 | $1.3M | Indirect | Apr 21, 2020 (1d) |
| Apr 16, 2020 | MYOV | ↑ Buy10b5-1 | 140,000 | $10.56 | $1.5M | Indirect | Apr 17, 2020 (1d) |
| Apr 14, 2020 | MYOV | ↑ Buy10b5-1 | 140,000 | $10.40 | $1.5M | Indirect | Apr 15, 2020 (1d) |
| Apr 9, 2020 | MYOV | ↑ Buy10b5-1 | 70,000 | $9.37 | $656K | Indirect | Apr 13, 2020 (4d) |
| Apr 8, 2020 | MYOV | ↑ Buy10b5-1 | 140,000 | $8.37 | $1.2M | Indirect | Apr 9, 2020 (1d) |
| Apr 6, 2020 | MYOV | ↑ Buy10b5-1 | 140,000 | $8.18 | $1.1M | Indirect | Apr 7, 2020 (1d) |
| Apr 2, 2020 | MYOV | ↑ Buy10b5-1 | 140,000 | $7.60 | $1.1M | Indirect | Apr 3, 2020 (1d) |
| Mar 31, 2020 | MYOV | ↑ Buy10b5-1 | 140,000 | $7.81 | $1.1M | Indirect | Apr 1, 2020 (1d) |
| Mar 27, 2020 | MYOV | ↑ Buy10b5-1 | 140,000 | $7.96 | $1.1M | Indirect | Mar 30, 2020 (3d) |
| Mar 25, 2020 | MYOV | ↑ Buy10b5-1 | 319,300 | $7.65 | $2.4M | Indirect | Mar 26, 2020 (1d) |
| Mar 23, 2020 | MYOV | ↑ Buy10b5-1 | 405,100 | $7.64 | $3.1M | Indirect | Mar 24, 2020 (1d) |
| Mar 19, 2020 | MYOV | ↑ Buy10b5-1 | 387,800 | $7.54 | $2.9M | Indirect | Mar 20, 2020 (1d) |
| Mar 17, 2020 | MYOV | ↑ Buy10b5-1 | 387,800 | $7.32 | $2.8M | Indirect | Mar 18, 2020 (1d) |
| Feb 19, 2020 | UROV | ↑ Buy | 103,250 | $13.08 | $1.4M | Indirect | Feb 21, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ROIV insiders
Open-market trades in the last 12 months
About Sumitomo Pharma Co., Ltd.'s insider trades
Sumitomo Pharma Co., Ltd. is a 10% owner of Roivant Sciences (ROIV). Since Feb 19, 2020, it has reported 42 open-market purchases worth $1.46B and 1 sale worth $130.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ROIV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.